
FILAMENT HEALTH ANNOUNCES FIRST-EVER COMPASSIONATE USE APPROVAL FOR PSILOCYBIN IN THE EUROPEAN UNION
VANCOUVER, BC, /CNW/ - Filament Health Corp. (OTC:FLHLF) (" Filament" or the " Company"), a clinical‐stage natural psychedelic drug development company, today announced the first-ever approval for compassionate use of psilocybin in the European Union (EU). The Company's botanical psilocybin drug candidate, PEX010, has been authorized for administration to a patient suffering from treatment-resistant depression (TRD) in Germany.
The approval was granted under Germany's compassionate use framework and marks the first time psilocybin will be prescribed outside of a clinical trial in the EU. The treatment will be conducted by Dr. Gerhard Gründer at the Central Institute of Mental Health, Department of Molecular Neuroimaging.
"This is a landmark moment for the field of psychedelic medicine in the European Union. Treatment-resistant depression affects up to 30% of individuals diagnosed with major depressive disorder and remains one of the most difficult psychiatric conditions to treat. Psilocybin has demonstrated significant promise as a novel therapeutic option, and this approval marks an important step toward expanding access for those in urgent need," said Dr. Gerhard Gründer. "I am honoured to play a role in expanding European access to psilocybin and grateful to the team at Filament Health for their support."
"The approval of PEX010 for this milestone moment in European psilocybin access reinforces Filament's position as the world's leading supplier of GMP-quality psychedelic drug candidates," said Benjamin Lightburn, Co-Founder and Chief Executive Officer at Filament Health. "We're incredibly proud that our drug product will be the first psilocybin to be administered under compassionate use in the EU. It's a validation of Filament's ongoing efforts to make safe, standardized psychedelic medicines available to those who need them most."
ABOUT FILAMENT HEALTH (OTC:FLHLF)
Filament Health is a clinical-stage natural psychedelic drug development company. We believe that safe, standardized, naturally-derived psychedelic medicines can improve the lives of many, and our mission is to see them in the hands of everyone who needs them as soon as possible. Filament's platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines for clinical development. We are paving the way with the first-ever natural psychedelic drug candidates.
Learn more at www.filament.health and on X, Instagram, and LinkedIn.
FORWARD LOOKING INFORMATION
Certain statements and information contained in this press release and the documents referred to herein may constitute "forward‐looking statements" and "forward‐looking information," respectively, under Canadian securities legislation. Generally, forward‐looking information can be identified by the use of forward‐looking terminology such as, "expect", "anticipate", "continue", "estimate", "may", "will", "should", "believe", "intends", "forecast", "plans", "guidance" and similar expressions are intended to identify forward‐looking statements or information. The forward‐looking statements are not historical facts, but reflect the current expectations of management of Filament regarding future results or events and are based on information currently available to them. Certain material factors and assumptions were applied in providing these forward‐looking statements. Forward‐looking statements regarding the Company are based on the Company's estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of Filament to be materially different from those expressed or implied by such forward‐looking statements or forward‐looking information, including the timing and results of clinical trials, the ability of the parties to receive, in a timely manner and on satisfactory terms, the necessary regulatory, court and shareholders approvals; the ability of the parties to satisfy, in a timely manner, the other conditions to the completion of the proposed business combination; other expectations and assumptions concerning the transactions contemplated in the proposed business combination; the available funds of the parties and the anticipated use of such funds; the availability of financing opportunities; legal and regulatory risks inherent in the psychedelic drug development industry; risks associated with economic conditions, dependence on management and currency risk; risks relating to U.S. regulatory landscape; risks relating to anti-money laundering laws and regulation; other governmental and environmental regulation; public opinion and perception of the psychedelic drug development industry; risks related to the economy generally; risk of litigation; conflicts of interest; risks relating to certain remedies being limited and the difficulty of enforcement of judgments and effect service outside of Canada; and risks related to future acquisitions or dispositions. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward‐ looking statements and forward‐looking information. Filament will not update any forward‐looking statements or forward‐looking information that are incorporated by reference herein, except as required by applicable securities laws.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Winnipeg Free Press
44 minutes ago
- Winnipeg Free Press
Manitoba's first hyperbaric oxygen therapy hub to open
Inside the chamber: a bed and pillow, a wrist strap, enough space for a 6 ft. 6 in. cotton gown-clad individual. Outside the chamber: Martin Hiebert, pointing to gauges and a phone attached to the vessel. 'You are in constant conversation with the patient,' Hiebert said. Ruth Bonneville / Free Press Martin Hiebert aims to open the St. James clinic at 1863 Portage Ave. on Sept. 1. Patients haven't yet laid in one of Prairie Hyperbarics' three chambers. Hiebert aims to open the St. James clinic on Sept. 1, marking Manitoba's first hyperbaric oxygen therapy (HBOT) hub. He gave the Free Press a tour of 1863 Portage Ave. ahead of time. Up to 21 clients will be treated daily. Health Canada recognizes HBOT as effective in treating 14 conditions. The range of ailments is vast — embolisms, carbon monoxide poisoning, crush injuries, decompression sickness, skin grafts. Clients will, most often, arrive with a prescription, Hiebert said. They'll enter a hyperbaric chamber room with three tubular chambers ready to pump a high concentration of oxygen into the body. Hiebert anticipates great demand: another three chambers could arrive within a year. 'The key here is to make (people) feel comfortable,' Hiebert said. Hence the TVs. Clients lying in each chamber for 80 minutes can watch movies. Meanwhile, they'll be consuming near-pure oxygen in four 15-minute stretches. Air composed of 94 per cent oxygen will circulate the enclosed tube. 'Compare it to 33 feet down in the water,' Hiebert described. 'That's the amount of pressure you get.' Ruth Bonneville / Free Press Martin Hiebert shows Prairie Hyberbarics' oxygen storage room. Those periods are broken by five-minute stretches of consuming typical breathing air, which has 21 per cent oxygen, via a supplied mask. It's a therapy that's grown since the 1950s. The goal is to 'fill the blood with enough oxygen to repair tissues and restore normal body function,' a summary by Johns Hopkins Medicine reads. Hiebert got exposed roughly eight years ago when he had prostate cancer and accompanying organ damage from its treatment. His oncologist recommended HBOT. However, there were no options in Manitoba, so Hiebert travelled to a Calgary clinic. It cost Manitoba Health around $35,000, Hiebert said. HBOT clinics have sprouted in Toronto and Vancouver. Several Canadian hospitals have hyperbaric units. Hiebert and business partner Dr. Karen Moran de Muller will run Prairie Hyperbarics, a private clinic. The College of Physicians and Surgeons of Manitoba has approved Moran de Muller as the site's medical director. Still pending is the CPSM accreditation needed before the clinic can operate. The association's Manitoba Quality Assurance Program has been in communication with the clinic, spokeswoman Wendy Elias-Gagnon wrote in an email. The accreditation process hasn't been started, but CPSM will work with Prairie Hyperbarics 'once the clinic is ready.' 'We're very close,' Hiebert said. Ruth Bonneville / Free Press Health Canada recognizes HBOT as effective in treating 14 conditions. Hiebert says a session at Prairie Hyperbarics will cost roughly $600. Later, he showed a thick binder Prairie Hyperbarics must adhere by to meet medical standards. Hiebert is envisioning athletes among the clients walking through the doors. A session will cost roughly $600, he said. He underwent 35 sessions in Calgary. An average case might involve daily sessions for 30 days, he said. He's in the midst of hiring two technicians to monitor treatments. The chambers can shut down in 120 seconds if need be. Another room holds a large fire extinguisher; it can fill the chamber room in 10 seconds, Hiebert said. The College of Physicians and Surgeons of Manitoba isn't aware of another accredited hyperbaric oxygen therapy chamber in the province, Elias-Gagnon confirmed. Shared Health doesn't oversee such chambers. 'We're really excited to have something at that level of innovation happening right in St. James,' said Melanie Maher, executive director of the St. James Village BIZ. 'It's really unique to bring it to the neighbourhood.' The new clinic comes with a $4.6 million start-up price tag, Hiebert said. Each Perry Baromedical hyperbaric chamber cost roughly $225,000. The clinic hasn't received government funding. Ruth Bonneville / Free Press Martin Hiebert, founder of Prairie Hyperbarics, underwent 35 HBOT sessions in Calgary eight years ago at the recommendation of his oncologist. Monday Mornings The latest local business news and a lookahead to the coming week. Hiebert believes Prairie Hyperbarics can save Manitoba Health money. Hyperbaric therapy would only be considered insured for critical care in a tertiary facility attached to care by a specialist, a provincial spokesperson wrote in a statement. 'While the province is open to further review, non-acute treatment is not currently covered in a private clinical setting,' the spokesperson continued. Hiebert is a marketing executive, and Moran de Muller is a family doctor practising out of Crestview Medical Clinic. Other family doctors may eventually join Prairie Hyperbarics — a wing of the 4,400 sq. ft. facility holds five offices for practitioners. Gabrielle PichéReporter Gabrielle Piché reports on business for the Free Press. She interned at the Free Press and worked for its sister outlet, Canstar Community News, before entering the business beat in 2021. Read more about Gabrielle. Every piece of reporting Gabrielle produces is reviewed by an editing team before it is posted online or published in print — part of the Free Press's tradition, since 1872, of producing reliable independent journalism. Read more about Free Press's history and mandate, and learn how our newsroom operates. Our newsroom depends on a growing audience of readers to power our journalism. If you are not a paid reader, please consider becoming a subscriber. Our newsroom depends on its audience of readers to power our journalism. Thank you for your support.

3 hours ago
China is fighting an outbreak of the chikungunya virus. What is it?
Chinese health officials are responding to an outbreak of a mosquito-borne virus that can cause severe pain. More than 7,000 cases of chikungunya have been reported in the Chinese province of Guangdong in recent weeks, with most in the southern city of Foshan. Reports from the region say those who are infected are being quarantined in hospital until they test negative for the virus, and workers are going to homes in Foshan to check for risk factors like standing water where mosquitoes can breed. Workers are also spraying parks and streets with insecticide, and authorities have released elephant mosquitoes and mosquito-eating fish to prey on the virus-carrying bugs. On Tuesday, the Canadian government added a Level 2 travel advisory (new window) encouraging travelers to practice enhanced health precautions if visiting China. What is chikungunya? Chikungunya is transmitted by infected female mosquitoes, most commonly the subspecies Aedes aegypti and Aedes albopictus — the same types that can transmit the Zika and dengue viruses, according to the World Health Organization (WHO). When a mosquito feeds on an infected person, it ingests the virus and can transmit it to other humans. The onset is typically four to eight days after the bite. Outbreaks and sporadic cases have been reported in various parts of the world, mostly concentrated in South America, Asia and Africa in recent decades. Smaller outbreaks have also been reported in Europe. The Pan American Health Organization has tracked (new window) more than 209,000 chikungunya cases in the Americas this year, with the highest numbers recorded in Brazil, and none in Canada. What are the symptoms? Chikungunya can cause fever and potentially debilitating joint pain. It can also cause muscle pain, headaches, nausea and rashes, according to the WHO. Symptoms typically last for several days and most people recover fully, but occasional cases of eye, heart and neurological complications have been reported, as well as joint pain lasting weeks to years. The main issue is that it causes a pretty significant joint pain, said infectious disease specialist Dr. Isaac Bogoch. Any joint in the body can be impacted, but it tends to impact the smaller joints of the hands and feet. Newborns, the elderly and and people with underlying health conditions are at the highest risk of severe symptoms and, in rare cases, death. According to the WHO, the name chikungunya derives from a word in the Kimakonde language of southern Tanzania, where the disease was first identified in 1952. The word means that which bends up, which describes the contorted posture of infected people with severe joint pain. Should Canadians be worried? Not according to Bogoch. He says it's not unusual for Canadian physicians to see travellers return with a variety of infections acquired abroad, including chikungunya. Canadian scientists are monitoring the presence of Aedes albopictus mosquitoes, which are not widespread in Canada but are established in the Windsor-Essex region of Ontario, according to the federal government (new window) . I don't think there's anything to freak out about. It's a well-known infection with well-known outbreaks, he told CBC News. You don't want to get this one, but we're not going to have an outbreak in Canada, at least in the 2025 calendar year. LISTEN | How to keep mosquitoes away (new window) A vaccine called IXCHIQ is licensed for use in Canada, but is not recommended for anyone over age 65 (new window) . Bogoch says the best strategy for travellers is to keep mosquitoes away as much as possible by wearing long sleeves and pants and by using insect repellant. He also recommends seeking free advice from travel clinics. There's parts of the world that have malaria that can be deadly, or other other various travel related risks, and a travel specialist can help navigate that so people can have a healthy, safe and happy trip, he said. Kevin Maimann (new window) · CBC News · Digital Writer Kevin Maimann is a senior writer for CBC News based in Edmonton. He has covered a wide range of topics for publications including VICE, the Toronto Star, Xtra Magazine and the Edmonton Journal. You can reach Kevin by email at


Cision Canada
3 hours ago
- Cision Canada
Government of Canada launches call for proposals for community projects to help seniors Français
VICTORIA, BC, Aug. 6, 2025 /CNW/ - Communities are stronger when every Canadian feels connected, supported and included. The New Horizons for Seniors Program (NHSP) creates opportunities for thousands of seniors to take the active role in their communities that they deserve. Today, the Honourable Stephanie McLean, Secretary of State (Seniors), launched the 2025–2026 call for proposals for community-based projects through the NHSP. Organizations are invited to apply for funding to support projects that will help seniors be connected and active members of their communities. These projects should reflect the four national priorities for this cycle: supporting healthy aging; preventing senior abuse; celebrating diversity and promoting inclusion; and supporting financial security. The Secretary of State made the announcement while visiting the Power To Be head office in Victoria. The organization received funding through the 2024–25 NHSP community-based stream that invested $60.3 million for 2,905 projects supporting seniors in more than 400 communities across Canada. Their new project, Pathways for Seniors, will allow volunteers to create events where seniors can mentor youth and others in their community, and share their knowledge. The NHSP funds a wide variety of projects, such as computer classes, financial literacy and fraud prevention education, meal deliveries, and intergenerational activities. The 2025–26 call for proposals is open until September 17, 2025. Quotes "I am thrilled that, for the past 21 years, the New Horizons for Seniors Program has funded 43,000 projects in hundreds of communities across Canada. This program continues to improve the quality of life of seniors in every part of the country." – The Honourable Stephanie McLean, Secretary of State (Seniors) "Power To Be has been providing access to nature and nature-based recreation for over 26 years. As a recipient of the New Horizon's for Seniors Program, we have convened a volunteer leadership team made up of six seniors who bring a rich diversity of experience, skillsets and connection to Power To Be. Based on their guidance, we are expanding our programmatic and volunteer offerings to meet the needs of more seniors in our community. Power To Be provides access to nature for people of all ages and abilities, and this new program is rooted in our values of accessibility, inclusion and connection to nature." – Dana Hutchings, Co-CEO, Power To Be Quick facts Seniors are one of Canada's fastest-growing population groups. They will represent almost 25% of the population by 2057 and could reach 11 million people within 15 years. The New Horizons for Seniors Program's community-based stream invests in projects that have a meaningful impact on communities and help to improve seniors' quality of life. Organizations are eligible to receive up to $25,000 in grant funding for projects of up to 52 weeks. Program funding supports projects that address one or more of the program's five objectives: promoting volunteerism among seniors and other generations; engaging seniors through the mentoring of others; expanding awareness of elder abuse, including financial abuse; supporting social participation and the inclusion of seniors; and providing capital assistance for new and existing community projects and programs for seniors. Project proposals must involve seniors in vital roles to lead, plan or deliver the project. Since its inception in 2004, the program has funded over 43,000 projects in hundreds of communities across Canada, with the Government of Canada investing more than $970 million. Based on the last two years of available data, more than 900,000 seniors benefit from NHSP community-based projects each year. Organizations can submit their applications electronically on the Grants and Contributions Online Services portal. Creating an account is a one-time process that allows organizations to apply for various Employment and Social Development Canada funding opportunities in a secure web environment. Organizations serving seniors can access support to prepare their application by contacting their nearest NHSP office. For details on how to apply, visit the New Horizons for Seniors Program webpage. New Horizons for Seniors Program – Community-based project funding Programs and services for seniors Follow us on X (Twitter) Follow us on Facebook SOURCE Employment and Social Development Canada